In Your Heart PDRN 20% Booster Shot 3ml
৳ 500.00
In Your Heart PDRN 20% Booster Shot 3ml is a concentrated skincare booster formulated with 20% PDRN to support hydrated, smoother and revitalized-looking skin. Ideal for skincare routines focused on improving skin texture, dullness and overall skin appearance.
In Your Heart PDRN 20% Booster Shot (3ml) represents the next evolution in Korean advanced skincare, designed for targeted micro-rejuvenation, intense barrier recovery, and deep elasticity restoration. Formulated with a high 20% concentration of Sodium DNA (PDRN extracted from salmon DNA), this intensive treatment mimics cellular regeneration to heal damaged skin tissues, fade stubborn acne scarring, and impart a glass-skin finish.
Product Overview & Core Attributes
| Feature | Specification |
| Product Name | In Your Heart PDRN 20% Booster Shot |
| Volume | 3 ml per ampoule shot |
| Key Active | 20% Polydeoxyribonucleotide (Salmon PDRN) |
| Category | K-Beauty Concentrated Booster / Microneedle-style Ampoule |
| Target Concerns | Fine lines, loss of firmness, post-acne marks, dullness, uneven texture |
Skin Benefits & Mechanism
-
Cellular Regeneration (PDRN Boost): Salmon DNA (PDRN) works at the tissue layer to promote collagen synthesis, accelerate skin cell renewal, and rebuild compromised skin barriers.
-
Glass Skin Luminosity: Fades hyperpigmentation, calms redness, and creates a dense hydration reservoir for a glowing finish.
-
Concentrated Delivery: The targeted 3ml booster shot format ensures maximum freshness and potency per application without exposure to air degradation.
How to Apply
-
Prep: Cleanse skin thoroughly and tone with a hydrating facial toner.
-
Dispense: Apply 2–3 drops of the In Your Heart PDRN 20% Booster Shot directly onto problem areas (fine lines, acne scars, hyperpigmentation) or across the whole face.
-
Absorb: Gently press and pat with warm fingertips until fully absorbed.
-
Lock In: Follow with a rich moisture cream or barrier repairing moisturizer.
Reviews
There are no reviews yet.